117 reports of this reaction
2.6% of all BUFFERED ASPIRIN reports
#7 most reported adverse reaction
NEPHROGENIC ANAEMIA is the #7 most commonly reported adverse reaction for BUFFERED ASPIRIN, manufactured by Lil' Drug Store Products, Inc.. There are 117 FDA adverse event reports linking BUFFERED ASPIRIN to NEPHROGENIC ANAEMIA. This represents approximately 2.6% of all 4,540 adverse event reports for this drug.
Patients taking BUFFERED ASPIRIN who experience nephrogenic anaemia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NEPHROGENIC ANAEMIA is a less commonly reported adverse event for BUFFERED ASPIRIN, but still significant enough to appear in the safety profile.
In addition to nephrogenic anaemia, the following adverse reactions have been reported for BUFFERED ASPIRIN:
The following drugs have also been linked to nephrogenic anaemia in FDA adverse event reports:
NEPHROGENIC ANAEMIA has been reported as an adverse event in 117 FDA reports for BUFFERED ASPIRIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
NEPHROGENIC ANAEMIA accounts for approximately 2.6% of all adverse event reports for BUFFERED ASPIRIN, making it a notable side effect.
If you experience nephrogenic anaemia while taking BUFFERED ASPIRIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.